FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ursula Plöckinger

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Ursula Plöckinger; W Saeger; S Schulz; P Vajkoczy; J Flitsch; M Geese; U Hoffmann; W Jakob; Amelie Lupp; Michael Buchfelder; Cord Dohrmann
DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours.
Ulrich-Frank Pape; Aurel Perren; Ursula Plöckinger; Ramon Salazar; Rudolf Arnold; Frederico Costa; Timm Denecke; Thomas Gress; David Gross; Ashley Grossman; Bruno Niederle
ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas.
Theo Daniel Kim; Michaela Schwarz; Hendrik Nogai; Peggy Grille; Jörg Westermann; Ursula Plöckinger; Doreen Braun; Ulrich Schweizer; Renate Arnold; Bernd Dörken; Philipp le Coutre
Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ursula Plöckinger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ursula Plöckinger; W Saeger; S Schulz; P Vajkoczy; J Flitsch; M Geese; U Hoffmann; W Jakob; Amelie Lupp; Michael Buchfelder; Cord Dohrmann
DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours.
European journal of endocrinology / European Federation of Endocrine Societies 2012;166(2):223-34.
2012: Ulrich-Frank Pape; Aurel Perren; Ursula Plöckinger; Ramon Salazar; Rudolf Arnold; Frederico Costa; Timm Denecke; Thomas Gress; David Gross; Ashley Grossman; Bruno Niederle
ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas.
Neuroendocrinology 2012;95(2):135-56.
2010: Theo Daniel Kim; Michaela Schwarz; Hendrik Nogai; Peggy Grille; Jörg Westermann; Ursula Plöckinger; Doreen Braun; Ulrich Schweizer; Renate Arnold; Bernd Dörken; Philipp le Coutre
Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia.
Thyroid : official journal of the American Thyroid Association 2010;20(11):1209-14.
2010: Andrea Frilling; Georgios C Sotiropoulos; Jun Li; Oskar Kornasiewicz; Ursula Plöckinger
Multimodal management of neuroendocrine liver metastases.
HPB : the official journal of the International Hepato Pancreato Biliary Association 2010;12(6):361-79.
2010: Marianne Pavel; Ashley Grossman; Rudolf Arnold; Aurel Perren; Gregory Kaltsas; Thomas Steinmüller; Wouter de Herder; George Nikou; Ursula Plöckinger; Jose Manuel Lopes; Hironobu Sasano; John Buscombe; Peter Lind; Dermot O'Toole; Kjell Oberg
ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors.
Neuroendocrinology 2010;91(4):326-32.
2010: Dermot O'Toole; Guido Rindi; Ursula Plöckinger; Bertram Wiedenmann
ENETS consensus guidelines for the management of patients with rare metastases from digestive neuroendocrine tumors: rationale and working framework. Introduction.
Neuroendocrinology 2010;91(4):324-5.
2010: Ursula Plöckinger; M Topuz; M Langer; T Reuter
Problems of diabetes management in the immigrant population in Germany.
Diabetes research and clinical practice 2010;87(1):77-86.
2009: Zoran Erlic; Lisa Rybicki; Mariola Peczkowska; Henriette Golcher; Peter H Kann; Michael Brauckhoff; Karsten Müssig; Michaela Muresan; Andreas Schäffler; Nicole Reisch; Matthias Schott; Martin Fassnacht; Giuseppe Opocher; Silke Klose; Christian Fottner; Flavio Forrer; Ursula Plöckinger; Stephan Petersenn; Dimitry Zabolotny; Oleg Kollukch; Svetlana Yaremchuk; Andrzej Januszewicz; Martin Walz; Charis Eng; Hartmut P H Neumann
Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(20):6378-85.
2009: Silke Meyer; Stephan Schaefer; Lisette Stolk; Pascal Arp; André G Uitterlinden; Ursula Plöckinger; Günter K Stalla; Ulrich Tuschy; Matthias M Weber; Alexander Weise; Andreas Pfützner; Peter H Kann
Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults.
Pharmacogenomics 2009;10(10):1599-608.
2009: Silke Meyer; Stephan Schaefer; Diana Ivan; Lisette Stolk; Pascal Arp; André G Uitterlinden; Peter P Nawroth; Ursula Plöckinger; Günter K Stalla; Ulrich Tuschy; Matthias M Weber; Alexander Weise; Andreas Pfützner; Peter H Kann
Growth hormone dose in growth hormone-deficient adults is not associated with IGF-1 gene polymorphisms.
Pharmacogenomics 2009;10(2):293-302.
2009: Rudolf Arnold; Yuan-Jia Chen; Frederico Costa; Massimo Falconi; David Gross; Ashley B Grossman; Rudolf Hyrdel; Beata Kos-Kudła; Ramon Salazar; Ursula Plöckinger
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation.
Neuroendocrinology 2009;90(2):227-33.
2009: Dik J Kwekkeboom; Eric P Krenning; Rachida Lebtahi; Paul Komminoth; Beata Kos-Kudła; Wouter W de Herder; Ursula Plöckinger
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs.
Neuroendocrinology 2009;90(2):220-6.
2009: Barbro Eriksson; Bruno Annibale; Emilio Bajetta; Emmanuel Mitry; Marianne Pavel; Marco Platania; Ramon Salazar; Ursula Plöckinger
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors.
Neuroendocrinology 2009;90(2):214-9.
2009: Göran Akerström; Massimo Falconi; Reza Kianmanesh; Philippe Ruszniewski; Ursula Plöckinger
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors.
Neuroendocrinology 2009;90(2):203-8.
2009: Dermot O'Toole; Ashley Grossman; David Gross; Gianfranco Delle Fave; Jaroslava Barkmanova; Juan O'Connor; Ulrich-Frank Pape; Ursula Plöckinger
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers.
Neuroendocrinology 2009;90(2):194-202.
2009: Ursula Plöckinger; Björn Gustafsson; Diana Ivan; Waldemar Szpak; Joseph Davar
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: echocardiography.
Neuroendocrinology 2009;90(2):190-3.
2009: Dik J Kwekkeboom; Eric P Krenning; Klemens Scheidhauer; Val Lewington; Rachida Lebtahi; Ashley Grossman; Pavel Vitek; Anders Sundin; Ursula Plöckinger
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide.
Neuroendocrinology 2009;90(2):184-9.
2009: Ursula Plöckinger; Bertram Wiedenmann; Wouter W de Herder
ENETS Consensus Guidelines for the Standard of Care in Neuroendocrine Tumors.
Neuroendocrinology 2009;90(2):159-61.
2009: Anders Sundin; Marie-Pierre Vullierme; Gregory Kaltsas; Ursula Plöckinger
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations.
Neuroendocrinology 2009;90(2):167-83.
2009: Kjell Oberg; Diego Ferone; Gregory Kaltsas; Ulrich Knigge; Babs Taal; Ursula Plöckinger
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biotherapy.
Neuroendocrinology 2009;90(2):209-13.
2009: Günter Klöppel; Anne Couvelard; Aurel Perren; Paul Komminoth; Anne-Marie McNicol; Ola Nilsson; Aldo Scarpa; Jean-Yves Scoazec; Bertram Wiedenmann; Mauro Papotti; Guido Rindi; Ursula Plöckinger
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.
Neuroendocrinology 2009;90(2):162-6.
2008: Ursula Plöckinger; Mendaha Topuz; Brigitte Riese; Thomas Reuter
Risk of exercise-induced hypoglycaemia in patients with type 2 diabetes on intensive insulin therapy: comparison of insulin glargine with NPH insulin as basal insulin supplement.
Diabetes research and clinical practice 2008;81(3):290-5.
2008: Silke Meyer; Marlitt Haist; Stephan Schaefer; Diana Ivan; Jochen R Ittner; Peter P Nawroth; Ursula Plöckinger; Günter K Stalla; Ulrich Tuschy; Matthias M Weber; Alexander Weise; Andreas Pfützner; Nils Habbe; Peter H Kann
Association of COLIA1 Sp1 polymorphism with the effect of subcutaneously injected recombinant hGH in GH-deficient adults.
Pharmacogenomics 2008;9(8):1017-26.
2008: Ursula Plöckinger; T Reuter
Pegvisomant increases intra-abdominal fat in patients with acromegaly: a pilot study.
European journal of endocrinology / European Federation of Endocrine Societies 2008;158(4):467-71.
2008: Ursula Plöckinger; Susann Albrecht; Christian Mawrin; Wolfgang Saeger; Michael Buchfelder; Stephan Petersenn; Stefan Schulz
Selective loss of somatostatin receptor 2 in octreotide-resistant growth hormone-secreting adenomas.
The Journal of clinical endocrinology and metabolism 2008;93(4):1203-10.
2008: Eva Göncz; Mathias Z Strowski; Carsten Grötzinger; Krzysztof W Nowak; Przemek Kaczmarek; Maciej Sassek; Stefan Mergler; Bilal F El-Zayat; Marily Theodoropoulou; Günter K Stalla; Bertram Wiedenmann; Ursula Plöckinger
Orexin-A inhibits glucagon secretion and gene expression through a Foxo1-dependent pathway.
Endocrinology 2008;149(4):1618-26.
2008: Nele Garbrecht; Martin Anlauf; Anja Schmitt; Tobias Henopp; Bence Sipos; Andreas Raffel; Claus F Eisenberger; Wolfram T Knoefel; Marianne Pavel; Christian Fottner; Thomas J Musholt; Anja Rinke; Rudolf Arnold; Uta Berndt; Ursula Plöckinger; Bertram Wiedenmann; Holger Moch; Philipp U Heitz; Paul Komminoth; Aurel Perren; Günter Klöppel
Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Endocrine-related cancer 2008;15(1):229-41.
2008: Barbro Eriksson; Günter Klöppel; Eric Krenning; Håkan Ahlman; Ursula Plöckinger; Bertram Wiedenmann; Rudolf Arnold; Christoph J Auernhammer; Meike Körner; Guido Rindi; Stefan Wildi
Consensus guidelines for the management of patients with digestive neuroendocrine tumors--well-differentiated jejunal-ileal tumor/carcinoma.
Neuroendocrinology 2008;87(1):8-19.
2008: Ursula Plöckinger; Anne Couvelard; Massimo Falconi; Anders Sundin; Ramon Salazar; Emanuel Christ; Wouter W de Herder; David Gross; WH Knapp; Ulrich Knigge; Matthew H Kulke; Ulrich-Frank Pape
Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma.
Neuroendocrinology 2008;87(1):20-30.
2007: Ursula Plöckinger; Denny Krüger; Alexandra Bergk; Viola Weich; Bertram Wiedenmann; Thomas Berg
Hepatitis-C patients have reduced growth hormone (GH) secretion which improves during long-term therapy with pegylated interferon-alpha.
The American journal of gastroenterology 2007;102(12):2724-31.
2007: Ursula Plöckinger; Bertram Wiedenmann
Treatment of gastroenteropancreatic neuroendocrine tumors.
Virchows Archiv : an international journal of pathology 2007;451 Suppl 1():S71-80.
2007: Vandana Singh; Carsten Grötzinger; Krzysztof W Nowak; Sylvia Zacharias; Eva Göncz; Gesine Pless; Igor M Sauer; Ines Eichhorn; Brigitte Pfeiffer-Guglielmi; Bernd Hamprecht; Bertram Wiedenmann; Ursula Plöckinger; Mathias Z Strowski
Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
Endocrinology 2007;148(8):3887-99.
2007: Jan M Langrehr; Marcus Bahra; Glen Kristiansen; Hartmut P H Neumann; Luitgard M Neumann; Ursula Plöckinger; Enrique Lopez-Hänninen
Neuroendocrine tumor of the pancreas and bilateral adrenal pheochromocytomas. A rare manifestation of von Hippel-Lindau disease in childhood.
Journal of pediatric surgery 2007;42(7):1291-4.
2007: Ursula Plöckinger; Bertram Wiedenmann
Neuroendocrine tumors. Biotherapy.
Best practice & research. Clinical endocrinology & metabolism 2007;21(1):145-62.
2007: Vandana Singh; Mathias D Brendel; Sylvia Zacharias; Stefan Mergler; Henning Jahr; Bertram Wiedenmann; Reinhard Bretzel; Ursula Plöckinger; Mathias Z Strowski
Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets.
The Journal of clinical endocrinology and metabolism 2007;92(2):673-80.
2007: Ursula Plöckinger
Diagnosis and treatment of gastric neuroendocrine tumours.
Wiener klinische Wochenschrift 2007;119(19-20):570-2.
2007: Stefan Mergler; Mathias Z Strowski; Simone Kaiser; Thomas Plath; Yvonne Giesecke; Marleen Neumann; Hiroshi Hosokawa; Shigeo Kobayashi; Jan M Langrehr; Peter Neuhaus; Ursula Plöckinger; Bertram Wiedenmann; Carsten Grötzinger
Transient receptor potential channel TRPM8 agonists stimulate calcium influx and neurotensin secretion in neuroendocrine tumor cells.
Neuroendocrinology 2007;85(2):81-92.
2005: Ursula Plöckinger; Bertram Wiedenmann
Endocrine tumours of the gastrointestinal tract. Management of metastatic endocrine tumours.
Best practice & research. Clinical gastroenterology 2005;19(4):553-76.
2005: Holger Amthauer; Timm Denecke; Torsten Rohlfing; Juri Ruf; Michael Böhmig; Matthias Gutberlet; Ursula Plöckinger; Roland Felix; Arne-Jörn Lemke
Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours.
European radiology 2005;15(7):1456-62.
2005: Suzanne Fateh-Moghadam; Ursula Plöckinger; Natalia Cabeza; Patrik Htun; T Reuter; S Ersel; Meinrad Gawaz; Rainer Dietz; Wolfgang Bocksch
Prevalence of aspirin resistance in patients with type 2 diabetes.
Acta diabetologica 2005;42(2):99-103.
2005: Suzanne Fateh-Moghadam; Zonyang Li; Simon Ersel; Thomas Reuter; Patrik Htun; Ursula Plöckinger; Wolfgang Bocksch; Rainer Dietz; Meinrad Gawaz
Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(6):1299-303.
2005: Ursula Plöckinger; Hans-Jürgen Quabbe
Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
Acta neurochirurgica 2005;147(5):485-93; discussion 493.
2004: Ursula Plöckinger; Bertram Wiedenmann
[Neuroendocrine tumours of the gastrointestinal tract].
Zeitschrift für Gastroenterologie 2004;42(6):517-27.
2004: Ulrich-Frank Pape; Michael Böhmig; Uta Berndt; Nikolaus Tiling; Bertram Wiedenmann; Ursula Plöckinger
Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center.
Annals of the New York Academy of Sciences 2004;1014():222-33.
2004: Holger Amthauer; Juri Ruf; Michael Böhmig; Enrique Lopez-Hänninen; Torsten Rohlfing; K-D Wernecke; Ursula Plöckinger; Matthias Gutberlet; Arne-Jörn Lemke; Thomas Steinmüller; Bertram Wiedenmann; Roland Felix
Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit?
European journal of nuclear medicine and molecular imaging 2004;31(3):342-8.
2004: Ursula Plöckinger; G Rindi; Rudolf Arnold; Barbro Eriksson; E P Krenning; Wouter W de Herder; Andrean Goede; M Caplin; K Oberg; J C Reubi; O Nilsson; G Delle Fave; P Ruszniewski; Håkan Ahlman; Bertram Wiedenmann
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).
Neuroendocrinology 2004;80(6):394-424.
2004: Ursula Plöckinger; Bertram Wiedenmann
Diagnosis of non-functioning neuro-endocrine gastro-enteropancreatic tumours.
Neuroendocrinology 2004;80 Suppl 1():35-8.
1999: Ursula Plöckinger; Jens J Holst; D Messerschmidt; Werner Hopfenmüller; Hans-Jürgen Quabbe
Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects.
European journal of endocrinology / European Federation of Endocrine Societies 1999;140(6):538-44.
1998: Ursula Plöckinger; Alejandra Perez-Canto; C Emde; Ralf-Marco Liehr; Werner Hopfenmüller; Hans-Jürgen Quabbe
Effect of the somatostatin analog octreotide on gastric mucosal function and histology during 3 months of preoperative treatment in patients with acromegaly.
European journal of endocrinology / European Federation of Endocrine Societies 1998;139(4):387-94.
1998: J Mayenknecht; Sven Diederich; Volker Bähr; Ursula Plöckinger; Wolfgang Oelkers
Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease.
The Journal of clinical endocrinology and metabolism 1998;83(5):1558-62.
1997: Ursula Plöckinger; M Bäder; Werner Hopfenmüller; Wolfgang Saeger; Hans-Jürgen Quabbe
Results of somatostatin receptor scintigraphy do not predict pituitary tumor volume- and hormone-response to ocreotide therapy and do not correlate with tumor histology.
European journal of endocrinology / European Federation of Endocrine Societies 1997;136(4):369-76.
1996: Hans-Jürgen Quabbe; Ursula Plöckinger
Metabolic aspects of acromegaly and its treatment.
Metabolism: clinical and experimental 1996;45(8 Suppl 1):61-2.
1994: Ursula Plöckinger; M Reichel; U Fett; W Saeger; Hans-Jürgen Quabbe
Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
The Journal of clinical endocrinology and metabolism 1994;79(5):1416-23.
1993: Ursula Plöckinger; Ralf-Marco Liehr; Hans-Jürgen Quabbe
Octreotide long term treatment of acromegaly: effect of drug withdrawal on serum growth hormone/insulin-like growth factor-I concentrations and on serum gastrin/24-hour intragastric pH values.
The Journal of clinical endocrinology and metabolism 1993;77(1):157-62.
1991: Ursula Plöckinger; Hans-Jürgen Quabbe
Evaluation of a repeatable depot-bromocriptine preparation(Parlodel LAR) for the treatment of acromegaly.
Journal of endocrinological investigation 1991;14(11):943-8.
1990: Ursula Plöckinger; D Dienemann; Hans-Jürgen Quabbe
Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly.
The Journal of clinical endocrinology and metabolism 1990;71(6):1658-62.
1989: Hans-Jürgen Quabbe; Ursula Plöckinger
Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
The Journal of clinical endocrinology and metabolism 1989;68(5):873-81.